The bioimpedance analyzers market is expected to grow at a compound annual growth rate (CAGR) of 9.8% from 2024 to 2032, from a worth of around USD 568 million in 2023 to USD 999.1 million in 2032. Bioimpedance Analyzers give users and medical professionals comprehensive insights into the body's measurements and support them in making educated decisions. The market is increasing and sustainable since it is in line with the healthcare industry.
Bioimpedance analyzers, also known as bioelectrical impedance analyzers (BIA), are noninvasive devices that determine body composition by delivering a small electrical current through the body and detecting the voltage. The body's electrolytic fluid volume is inversely proportional to the measured resistance. Lean body mass, fat mass, percentage of mass, total body water, extracellular fluid, body cell mass, and intercellular water can all be calculated.

Request For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/bioimpedance-analyzers-market

GROWTH DRIVERS
The need for precise body composition measurement is driven by the rising prevalence of obesity and lifestyle diseases like diabetes and cardiovascular disorders. The World Health Organization (WHO) estimates that 16% of persons globally who are 18 years of age or older are obese in 2022—more than twice as many as in 1990. At least 120 million children and adolescents and over 670 million adults make up the global total of over 1 billion people.
As per a recent analysis by the Global Wellness Institute, the wellness sector has experienced growth from $3.4 trillion in 2013 to $8.5 trillion by 2027, which is over twice the size of Germany's gross domestic product. The business is predicted to increase by an additional 57%. The market is expected to grow due to the growing number of elderly individuals, which highlights the importance of routine health monitoring. The WHO estimates that 771 million individuals worldwide, or about 10% of the global population, were 65 years of age or older in 2022.
The number of individuals 60 and older is predicted to double, reaching 1.4 billion by 2030 and 2.1 billion by 2050. The proportion of people 65 and older worldwide is predicted to rise to 16% by 2050. The market is growing because it is possible to track and analyze body composition data over time by integrating it with digital health platforms.
MARKET SEGMENTATION:
· By Device Type– Single frequency bioimpedance analyzers, dual-frequency bioimpedance analyzers and multiple-frequency bioimpedance analyzers
· By Application – Segmental body measurement and whole-body measurement
· By Modality - Wire and wireless bioimpedance analyzers
· By End-User- Hospitals & Clinics, Fitness and wellness centers, home user settings and others
· By Region- North America, Europe, Asia Pacific, The Middle East and Africa, South America
Global Key Players:
· Tanita Corporation
· Seca GmbH & Co. KG
· Maltron International Ltd.
· Akern
· RJL Systems
· Accuniq (SELVAS Healthcare)
· InBody Co., Ltd.
· Bodystat Ltd.
· Omron Corporation
· Charder Medical

For More Information about this Report @ https://www.xresearch.biz/shop/bioimpedance-analyzers-market

About Us: -
xResearch is a market research and consulting organization that uses unique data, expert analysis, and new technologies to create trusted intelligence on industries. Our research is focused on delivering an informed and impartial view on essential market data of industry, and it is primarily driven by an in-depth study covering the following parameters: Market Sizing and Forecasting, Market Segmentation, Competitive Analysis, Strategic Assessment and Business Modelling.

Contact:
Company Name: xResearch
Contact Person: James Lin
Email: [email protected]
Phone: +1 718-618-4545